A Phase IV Study on Safety, Tolerability and Efficacy of Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate in Treatment Naïve Adult Indian Patients Living with HIV-1

PURPOSE: WHO recommends dolutegravir (DTG) based regimens as first-line treatment for HIV-1 infection. However, few studies have been conducted in Indian population. Hence, our study evaluated the safety, tolerability, and efficacy of DTG 50 mg with Tenofovir and Lamivudine (300/300mg) fixed dose co...

Descripción completa

Detalles Bibliográficos
Autores principales: Dravid, Ameet, Morkar, Dnyanesh, Prasad, Dwijendra, Ramapuram, John T, Patel, Kartik Vikrambhai, Naik, K Sunil, Bhrusundi, Milind, Kulkarni, Milind, Hegde, Sanjeev, Anuradha, S, Nageswaramma, Siddabathuni, Madan, Surabhi, Jayaprakash, Thammisetty, Kulkarni, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375976/
https://www.ncbi.nlm.nih.gov/pubmed/35975180
http://dx.doi.org/10.2147/POR.S361907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375976/
https://www.ncbi.nlm.nih.gov/pubmed/35975180
http://dx.doi.org/10.2147/POR.S361907

Ejemplares similares